You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

~ Buy the ZINC Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

ZINC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zinc patents expire, and when can generic versions of Zinc launch?

Zinc is a drug marketed by Pharmafair, Exela Pharma, Hospira, Abraxis Pharm, Am Regent, Apotex, Fresenius Kabi Usa, Gland Pharma Ltd, Nivagen Pharms Inc, Somerset Theraps Llc, and Zydus Pharms. and is included in eleven NDAs.

The generic ingredient in ZINC is zinc sulfate. There are thirty-eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the zinc sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zinc

A generic version of ZINC was approved as zinc sulfate by AM REGENT on July 18th, 2019.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZINC?
  • What are the global sales for ZINC?
  • What is Average Wholesale Price for ZINC?
Summary for ZINC
US Patents:0
Applicants:11
NDAs:11
Drug Prices: Drug price information for ZINC
Drug Sales Revenues: Drug sales revenues for ZINC
What excipients (inactive ingredients) are in ZINC?ZINC excipients list
DailyMed Link:ZINC at DailyMed
Drug patent expirations by year for ZINC
Drug Prices for ZINC

See drug prices for ZINC

Drug Sales Revenue Trends for ZINC

See drug sales revenues for ZINC

US Patents and Regulatory Information for ZINC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062389-001 Jul 2, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Somerset Theraps Llc ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 216135-001 Jul 17, 2024 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 209377-001 Jul 18, 2019 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abraxis Pharm ZINC SULFATE zinc sulfate INJECTABLE;INJECTION 019229-002 May 5, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 216249-003 Sep 1, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms ZINC SULFATE zinc sulfate SOLUTION;INTRAVENOUS 217074-003 Aug 22, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.